We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Bayer, ERS Genomics Announce Licensing Agreement

News   May 18, 2016

 
Bayer, ERS Genomics Announce Licensing Agreement
 
 
Advertisement
 

RELATED ARTICLES

Phase 1 Clinical Trial of University of Queensland COVID-19 Vaccine Begins

News

The first participants were enrolled into a Phase 1 clinical trial of the University of Queensland’s (UQ) COVID-19 vaccine candidate on July 13.

READ MORE

Creating an Artificial Energy Source To Power Muscles

News

A new study in the Biophysical Journal outlines the work of scientists who have created a series of compounds that could serve as an alternative synthetic energy source for myosin.

READ MORE

No NELL2, No Sperm Motility

News

Researchers have discovered a novel testicular luminal protein, NELL2, that triggers in the epididymis a chain of events that matures the sperm and enables each one to be motile in females.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE